serological – Page 39 – Communicable Diseases Research

Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men

남성의 무증상 COVID-2019 감염의 회복기 동안의 급성 허혈성 뇌졸중

Research

Published on 2021-04-222022-09-25
Journal: JAMA Network Open [Category] MERS, SARS, 임상, 진단,

Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland

Article

Published on 2021-04-212022-10-28
Journal: Vaccines [Category] COVID-19,

Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies

SARS-CoV-2 항체 검출을 위한 혈청학적 분석법의 비교

Comparative Study

Published on 2021-04-202022-09-01
Journal: Viruses [Category] MERS, SARS, 진단, 치료기술,

[키워드] Antibody detection Antibody Response Antibody test antibody tests biosafety biosafety level Cohort Combination convalescent convalescent plasma coronavirus correlated strongly correlation COVID-19 COVID-19 patient cross-reactivity detect detection detection rate diagnostic discrimination Efficiency ELISA ENhance exposure to healthy individual healthy individuals hospital humans IgG IgG ELISA Infection infection with COVID-19 lentivirus neutralisation test neutralization positive provided pseudotype neutralisation Research SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 pseudotype virus SARS-CoV-2 virus SARS-CoV-2-N Screen sensitivities sensitivity serological serum severe disease spike glycoproteins utility Virus neutralisation VNT was performed
[DOI] 10.3390/v13040713 PMC 바로가기 [Article Type] Comparative Study

Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors

Full Length Article

Published on 2021-04-202022-10-29
Journal: Practical Laboratory Medicine [Category] COVID-19,

[키워드] anti-SARS-CoV-2 antibody Antibody neutralization Antibody Response Antigen AUC, area under the curve Correlate of protection correlation COVID COVID-19 COVID-19, Coronavirus disease 2019 cut off cut-off value diagnostic value Donor ECDC, European Centre for Disease Prevention and Control ELISA ELISA kit ELISA test epidemiological epidemiological survey examined expected gold standard greater identify individual Infection information moderate NAbs, neutralizing antibodies NC, Nucleocapsid neutralization neutralization activity neutralize Neutralizing activity nucleocapsid OD, optical density onset of symptom performed plasma predict Protein ranged RBD RBD antigen response to vaccination responses against ROC, Receiver Operating Characteristic S1, Spike protein 1 S2, Spike protein 2 SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 Sensitivity and specificity serological serological test serum sample Spearman correlation coefficient specificity Test tested therapeutic vaccinated individuals virus Virus neutralization virus neutralization test VNT, virus neutralization test were measured
[DOI] 10.1016/j.plabm.2021.e00222 PMC 바로가기 [Article Type] Full Length Article

SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020

Observational Study

Published on 2021-04-152022-10-04
Journal: Eurosurveillance [Category] MERS, SARS, 임상,

[키워드] affected antibody Asymptomatic attack rate children circulation cohort study Complete Coronavirus disease 2019 (COVID-19) Coronavirus infection Emerging infectious diseases Epidemiology France French HKU1 Infection introduced investigated measure Measures OC43 occur outbreak parent Participants Prevalence pupil Pupils questionnaire Result retrospective SARS-CoV-2 SARS-CoV-2 antibody testing SARS-CoV-2 epidemiology SARS-COV-2 infection SARS-CoV-2 transmission School Schools secondary case serological seropositive Study participants Surveillance Symptom symptomatic symptomatic case Transmission
[DOI] 10.2807/1560-7917.ES.2021.26.15.2001695 PMC 바로가기 [Article Type] Observational Study

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination

mRNA 백신 접종 후 SARS-CoV-2 미경험 및 회복된 개인에서 뚜렷한 항체 및 기억 B 세포 반응

Research Articles

Published on 2021-04-152022-09-10
Journal: Science Immunology [Category] MERS, SARS, 변종, 진단,

[키워드] addition age analyses antibodies antibody Antigen antigen-specific memory B cells B cells B.1.351 B.1.351 variant Cell cellular cellular response Cellular responses circulating antibodies clinical trials correlated COVID-19 declined demonstrated detectable distribution dose Efficacy Emergency use full-length spike protein highlight immune responses increases in individual individuals memory memory B memory B cell memory B cells mRNA mRNA vaccination mRNA vaccine mRNA vaccines naïve naïve individual Neutralizing titer neutralizing titers no increase novel priming RBD recall Receptor binding domain required response responses robust SARS-CoV-2 SARS-CoV-2 antigens SARS-CoV-2 vaccine second dose serological serology significantly single vaccine Spike protein Spike receptor binding domain subject subjects titers utility Vaccine vaccine dose vaccine-induced immune response
[DOI] 10.1126/sciimmunol.abi6950 PMC 바로가기 [Article Type] Research Articles

A Perspective on COVID-19 Management

Review

Published on 2021-04-092022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Evaluation of a Broad Panel of SARS-CoV-2 Serological Tests for Diagnostic Use

Article

Published on 2021-04-082022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave

코로나19 감염 후 의심되는 누락, 후기 또는 사후 감염 증후군의 진단 및 관리를 지원하기 위한 표적 SARS-CoV-2 혈청 검사의 임상적 유용성: 첫 번째 유행성 유행 기간 동안 구현된 파일럿 서비스의 결과

Clinical Trial

Published on 2021-04-072022-09-10
Journal: PLoS ONE [Category] MERS, SARS, 임상, 진단, 치료기술, 치료제,

[키워드] anti-spike antibodies anti-spike antibody antibodies benefit Care central London Characteristics children clinical clinical utility COVID-19 COVID-19 pandemic defined detect detectable diagnose diagnoses Diagnosis experience feasibility First wave followed by help hospital Immunosuppression indication indications individual Infection infection control Interpretation Intervention lateral flow immunoassay LFIA LFIAs management pandemic participant Patient PCR positive performed positive individual practicality Probability provided Pulmonary embolism required Result SARS-CoV-2 SARS-CoV-2 RNA serological Serological assay serological assays Serological testing serology serology testing serum service specificity Surescreen triggered urgency utility were recorded
[DOI] 10.1371/journal.pone.0249791 PMC 바로가기 [Article Type] Clinical Trial

IgG and IgM antibody formation to spike and nucleocapsid proteins in COVID-19 characterized by multiplex immunoblot assays

다중 면역블롯 분석을 특징으로 하는 COVID-19에서 스파이크 및 뉴클레오캡시드 단백질에 대한 IgG 및 IgM 항체 형성

Research Article

Published on 2021-04-072022-09-01
Journal: BMC Infectious Diseases [Category] MERS, 진단, 치료법, 치료제,

[키워드] allergy antibody antibody formation Antibody Response Antibody responses Antigen Antisera assays autoimmune condition autoimmune conditions caused characterized COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients criteria detection diagnostic tests Diseases IgG IgG and IgM IgM IgM antibodies IgM antibody immunoblot Influenza Laboratory less Line immunoblot assay mild symptoms multiplex Multiplex assay N proteins nucleocapsid protein offer performed plateau positive Positive test proportion proportions Proteins qPCR test Rapid RBD Receptor binding domain Receptor-binding domain recombinant Recombinant nucleocapsid protein recommendation Result RT-qPCR RT-qPCR test SARS-CoV-2 SARS-CoV-2 protein SARS-CoV-2 proteins SARS-CoV-2 virus SARS-CoV-2 virus protein SARS-CoV-2 virus proteins sensitivity sera Seroconversion serological Serological assay Serological diagnosis Specificities specificity Spike protein spike protein of SARS-CoV-2 supplementary material the spike protein Viral viral infections were used
[DOI] 10.1186/s12879-021-06031-9 PMC 바로가기 [Article Type] Research Article